| Name | Title | Contact Details |
|---|
Unlike traditional approaches that only address symptoms, Cardionomic addresses the conditions root cause of reduced contractility. The therapy uses neuromodulation to benignly increase contractility, thus improving cardiac output therefore increasing renal flow and end organ perfusion. Benignly increasing contractility decreases negative hormonal signaling, and improves in-hospital morbidity/mortality. This breakthrough therapy is also expected to increase pharmacological tolerance at discharge, which will reduce costly readmission and extend life. Spun off from Denali Medical II, a New Enterprise Associates (NEA) backed incubator, Cardionomic is funded by NEA, Greatbatch Medical and Cleveland Clinic Foundation.
Life Center Organ Donor Ntwrk is a Cincinnati, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Can-Med Healthcare is a Bedford, NS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
ScienceBased Health is a Houston, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Texas Health Action is a non-profit organization that provides access to culturally affirming, quality health services in a safe and supportive environment with an expertise in serving LGBTQIA+ people and people impacted by HIV.